These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 6810283

  • 1. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
    Thabaut A, Durosoir JL.
    Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
    [Abstract] [Full Text] [Related]

  • 2. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P, Renaudin H, Quentin C, Bebear C.
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
    Lesage D, Delisle-Mizon F, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 May; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 5. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J, Le Noc P, Bryskier A, Robert J.
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [Abstract] [Full Text] [Related]

  • 6. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G, Freiesleben H, Marre R, Metz H, Tannenberg H, Pulverer G.
    Dtsch Med Wochenschr; 1979 Jun 29; 104(26):946-8. PubMed ID: 110574
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct 29; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 8. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL, O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Oct 29; 11(4):259-62. PubMed ID: 2941258
    [Abstract] [Full Text] [Related]

  • 9. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
    Thibault M, Koumaré B, Soussy CJ, Duval J.
    Ann Microbiol (Paris); 1981 Oct 29; 132(3):267-81. PubMed ID: 6457546
    [Abstract] [Full Text] [Related]

  • 10. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO, Izard D, Leclerc H.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec 29; 258(2-3):283-6. PubMed ID: 6241772
    [Abstract] [Full Text] [Related]

  • 11. [Variations in vitro of the efficacy of quinolones as a function of pH].
    François B, Gille Y, Schmuck N, Assenat H, Adeleine P, Davoine P.
    Nephrologie; 1983 Dec 29; 4(6):259-62. PubMed ID: 6669186
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
    Neu HC, Chin NX, Labthavikul P, Saha G.
    Chemioterapia; 1984 Aug 29; 3(4):235-41. PubMed ID: 6241847
    [Abstract] [Full Text] [Related]

  • 13. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO, Izard D, Bryskier A, Leclerc H.
    Chemioterapia; 1985 Aug 29; 4(4):278-83. PubMed ID: 3863716
    [Abstract] [Full Text] [Related]

  • 14. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Aug 29; 11(4):253-7. PubMed ID: 2941257
    [Abstract] [Full Text] [Related]

  • 15. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
    Esposito S, Galante D, Pennucci C, Barba D.
    Microbiologica; 1985 Jul 29; 8(3):269-76. PubMed ID: 3162081
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE, Wickerhoff-Minoggio T.
    J Antimicrob Chemother; 1985 Oct 29; 16(4):485-90. PubMed ID: 3864776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
    Berardi-Grassias LD, Roy O.
    Pathol Biol (Paris); 1987 May 29; 35(5):467-72. PubMed ID: 3112705
    [Abstract] [Full Text] [Related]

  • 20. [In vitro study of the combination of pefloxacin with other antibiotics against Pseudomonas aeruginosa and Streptococcus group D].
    Zuccarelli M, Attisso MA, Simeon de Buochberg M, Dusart G.
    Pathol Biol (Paris); 1987 May 29; 35(5):581-5. PubMed ID: 3112710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.